IRCT20151228025732N72Recruiting未知
Evaluation of the effect of vaginal progesterone administration on ultrasonographic indicators and fetal and pregnancy outcomes of women at high risk of preeclampsia
Semnan University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- Female
Inclusion Criteria
- •Age 18 and above
- •Body mass index above 30
- •The interval between pregnancies is more than 10 years
- •Multiple pregnancy
- •Pre-gestational diabetes
- •Live singleton fetus
Exclusion Criteria
- •Heart, liver, thyroid diseases, history of asthma
- •Aspirin sensitivity
- •Threatened abortion such as vaginal bleeding
- •Eclampsia and pre-eclampsia at the time of study
Investigators
Similar Trials
Completed
Phase 2
Vaginal Progesterone effect on pregnancy rate in infertility women with polycystic ovarian syndromeInfertility and Polycystic Ovarian Syndrome.Polycystic ovarian syndromeIRCT201206072967N4Vice chancellor of research, Kashan University of Medical Sciences200
Completed
Phase 3
Evaluation of the effect of vaginal Progesterone in preventing preterm laborprevention of preterm labor.Preterm labourIRCT138706051096N1Vice Chancellor for research-Guilan University of Medical Sciences260
Recruiting
Phase 3
Comparison of the effect of vaginal progesterone on uterine Doppler findings in early-onset preeclampsiaPre-eclampsiaIRCT20210127050156N1Karaj University of Medical Sciences80
Active, not recruiting
Phase 1
The Effect of Vaginal Progesterone Administration in the prevention of Preterm Birth in Women with Short Cervix, [also Known as: Vaginal progesterone bioadhesive gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix-Trial (PREGNANT Short Cervix-Trial)] - PREGNANT Short Cervix-TrialPreterm birth (less than or equal to 32 6/7 weeks gestation)EUCTR2008-007498-19-CZColumbia Laboratories, Inc450
Completed
Phase 2
effect of progestron in preterm laborpre term labor.Onset (spontaneous) of labour before 37 completed weeks of gestationIRCT2014123120504N1Vice chancellor for research, Tehran University of Medical Sciences182